Cargando…

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43

Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raise...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun-Kyoung, Lee, Byoung-Hee, Seok, Seung-Hyeok, Baek, Min-Won, Lee, Hui-Young, Kim, Dong-Jae, Na, Yi-Rang, Noh, Kyoung-Jin, Park, Sung-Hoon, Kumar, Dutta Noton, Kariwa, Hiroaki, Nakauchi, Mina, Heo, Suk-Jin, Park, Jae-Hak
Formato: Texto
Lenguaje:English
Publicado: The Korean Society of Veterinary Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873818/
https://www.ncbi.nlm.nih.gov/pubmed/20458159
http://dx.doi.org/10.4142/jvs.2010.11.2.165
_version_ 1782181401006702592
author Lee, Hyun-Kyoung
Lee, Byoung-Hee
Seok, Seung-Hyeok
Baek, Min-Won
Lee, Hui-Young
Kim, Dong-Jae
Na, Yi-Rang
Noh, Kyoung-Jin
Park, Sung-Hoon
Kumar, Dutta Noton
Kariwa, Hiroaki
Nakauchi, Mina
Heo, Suk-Jin
Park, Jae-Hak
author_facet Lee, Hyun-Kyoung
Lee, Byoung-Hee
Seok, Seung-Hyeok
Baek, Min-Won
Lee, Hui-Young
Kim, Dong-Jae
Na, Yi-Rang
Noh, Kyoung-Jin
Park, Sung-Hoon
Kumar, Dutta Noton
Kariwa, Hiroaki
Nakauchi, Mina
Heo, Suk-Jin
Park, Jae-Hak
author_sort Lee, Hyun-Kyoung
collection PubMed
description Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raised polyclonal and monoclonal antibodies (Abs) using a recombinant form of the SARS virus nucleocapsid protein. Cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 were determined by Western blotting. The Abs produced reacted with recombinant SARS virus nucleocapsid protein, but not with HCoV 229E or HCoV OC43.
format Text
id pubmed-2873818
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Korean Society of Veterinary Science
record_format MEDLINE/PubMed
spelling pubmed-28738182010-06-01 Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43 Lee, Hyun-Kyoung Lee, Byoung-Hee Seok, Seung-Hyeok Baek, Min-Won Lee, Hui-Young Kim, Dong-Jae Na, Yi-Rang Noh, Kyoung-Jin Park, Sung-Hoon Kumar, Dutta Noton Kariwa, Hiroaki Nakauchi, Mina Heo, Suk-Jin Park, Jae-Hak J Vet Sci Short Communication Severe acute respiratory syndrome (SARS) is a life-threatening disease for which accurate diagnosis is essential. Although many tools have been developed for the diagnosis of SARS, false-positive reactions in negative sera may occur because of cross-reactivity with other coronaviruses. We have raised polyclonal and monoclonal antibodies (Abs) using a recombinant form of the SARS virus nucleocapsid protein. Cross-reactivity of these anti-SARS Abs against human coronavirus (HCoV) 229E and HCoV OC43 were determined by Western blotting. The Abs produced reacted with recombinant SARS virus nucleocapsid protein, but not with HCoV 229E or HCoV OC43. The Korean Society of Veterinary Science 2010-06 2010-05-11 /pmc/articles/PMC2873818/ /pubmed/20458159 http://dx.doi.org/10.4142/jvs.2010.11.2.165 Text en Copyright © 2010 The Korean Society of Veterinary Science https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Lee, Hyun-Kyoung
Lee, Byoung-Hee
Seok, Seung-Hyeok
Baek, Min-Won
Lee, Hui-Young
Kim, Dong-Jae
Na, Yi-Rang
Noh, Kyoung-Jin
Park, Sung-Hoon
Kumar, Dutta Noton
Kariwa, Hiroaki
Nakauchi, Mina
Heo, Suk-Jin
Park, Jae-Hak
Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title_full Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title_fullStr Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title_full_unstemmed Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title_short Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
title_sort production of specific antibodies against sars-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229e and oc43
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873818/
https://www.ncbi.nlm.nih.gov/pubmed/20458159
http://dx.doi.org/10.4142/jvs.2010.11.2.165
work_keys_str_mv AT leehyunkyoung productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT leebyounghee productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT seokseunghyeok productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT baekminwon productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT leehuiyoung productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT kimdongjae productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT nayirang productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT nohkyoungjin productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT parksunghoon productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT kumarduttanoton productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT kariwahiroaki productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT nakauchimina productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT heosukjin productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43
AT parkjaehak productionofspecificantibodiesagainstsarscoronavirusnucleocapsidproteinwithoutcrossreactivitywithhumancoronaviruses229eandoc43